← Back to Analyst Consensus 
THC Buy
TENET HEALTHCARE CORP
Current Price —
Implied Upside —
Analysts 28
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Sep 23, 2026 | BMO Capital | initiate | — → Market Perform | — | 53% |
| Sep 18, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Aug 3, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 28, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Jul 28, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jul 28, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 27, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 27, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 20, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 13, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 9, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jun 22, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 5, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 5, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| May 4, 2026 | Stephens & Co. | maintain | Overweight → Overweight | — | 54% |
| May 1, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 1, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 1, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 1, 2026 | Keybanc | maintain | Overweight → Overweight | — | 53% |
| Mar 12, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 12, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Feb 20, 2026 | Leerink Partners | maintain | Outperform → Outperform | $264 | 50% |
| Feb 17, 2026 | Truist Securities | maintain | Buy → Buy | $270 | 55% |
| Feb 13, 2026 | Barclays | maintain | Overweight → Overweight | $257 | 53% |
| Feb 13, 2026 | Guggenheim | maintain | Buy → Buy | $271 | 52% |
| Feb 12, 2026 | Jefferies | maintain | Buy → Buy | $265 | 52% |
| Feb 12, 2026 | RBC Capital | maintain | Outperform → Outperform | $277 | 55% |
| Feb 12, 2026 | UBS | maintain | Buy → Buy | $288 | 54% |
| Feb 12, 2026 | Keybanc | maintain | Overweight → Overweight | $250 | 53% |
| Feb 3, 2026 | RBC Capital | maintain | Outperform → Outperform | $253 | 55% |
| Jan 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | $229 | 54% |
| Jan 7, 2026 | TD Cowen | maintain | Buy → Buy | $230 | 54% |
| Dec 2, 2025 | Guggenheim | maintain | Buy → Buy | $257 | 52% |
| Nov 21, 2025 | Barclays | maintain | Overweight → Overweight | $240 | 53% |
| Nov 13, 2025 | JP Morgan | maintain | Overweight → Overweight | $230 | 54% |
| Nov 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $252 | 54% |
| Nov 3, 2025 | Truist Securities | reiterate | Buy → Buy | $240 | 55% |
| Oct 30, 2025 | RBC Capital | maintain | Outperform → Outperform | $252 | 55% |
| Oct 29, 2025 | UBS | maintain | Buy → Buy | $260 | 54% |
| Oct 29, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $245 | 50% |
| Oct 29, 2025 | Guggenheim | maintain | Buy → Buy | $238 | 52% |
| Oct 17, 2025 | Mizuho | maintain | Outperform → Outperform | $225 | 52% |
| Oct 8, 2025 | Keybanc | maintain | Overweight → Overweight | $225 | 53% |
| Oct 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $238 | 54% |
| Oct 7, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $190 | 50% |
| Sep 18, 2025 | Barclays | maintain | Overweight → Overweight | $229 | 53% |
Price Target Trend
Jun 18, 2026 Latest: $286.41 Oct 24, 2026
EPS Estimates
0q $4.68
Lo: $4.03 Hi: $5.11
20 analysts +1y $21.09
Lo: $18.89 Hi: $23.21
21 analysts 0y $21.23
Lo: $20.66 Hi: $21.65
21 analysts +1q $5.67
Lo: $5.18 Hi: $6.59
20 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days